-1787

9
25 A +1 -1787 +19 hMLH1 B Acetylated H3 Enrichment -1 1 3 5 7 9 -1800 -1300 -800 -300 SW480 RKO Position from +1 B B I I + + - - SW480 B I B I + + - - RKO C hMLH1 GAPDH Ab D Methyl-H3-K4 enrichment -1 1 3 5 7 9 11 -1800 -1300 -800 -300 Position from +1 SW480 RKO SW480 B B I I + + - - RKO B I B I + + - - E GAPDH hMLH1 Ab Figure 1 F Methyl-H3-K9 enrichment Position from +1 -1 1 3 5 7 -1800 -1300 -800 -300 SW480 RKO GAPDH hMLH1 Ab SW480 B B I I + + - - B I B I + + -- G RKO

description

+1. hMLH1. -1787. +19. B. C. SW480. RKO. SW480. RKO. Acetylated H3 Enrichment. +. +. -. -. +. +. -. -. Ab. SW480. SW480. RKO. RKO. B. I. B. I. B. I. B. I. hMLH1. GAPDH. Position from +1. D. E. RKO. SW480. +. +. -. -. +. +. -. -. Ab. Methyl-H3-K4 - PowerPoint PPT Presentation

Transcript of -1787

Page 1: -1787

25

A +1

-1787 +19

hMLH1

B

Ace

tyla

ted

H3

Enr

ichm

ent

-1

1

3

5

7

9

-1800 -1300 -800 -300

SW480RKO

Position from +1

BB I I

+ + - -

SW480

B IBI

+ + - -

RKO

C

hMLH1

GAPDH

Ab

D

Met

hyl-

H3-

K4

enri

chm

ent

-1

1

3

5

7

9

11

-1800 -1300 -800 -300

Position from +1

SW480RKO

SW480

BB I I

+ + - -

RKO

B IBI

+ + - -

E

GAPDH

hMLH1

Ab

Figure 1

F

Met

hyl-

H3-

K9

enri

chm

ent

Position from +1

-1

1

3

5

7

-1800 -1300 -800 -300

SW480RKO

GAPDH

hMLH1

Ab

SW480

BB I I

+ + - -

B IBI

+ + - -

GRKO

Page 2: -1787

27

Figure 2

-1

0

1

2

-1800 -1300 -800 -300

Met

hyl-

H3-

K4

enri

chm

ent

B B BB I III

TSA++ ++--- -Ab-++ + + ---

hMLH1

GAPDH

C

Position from +1

D-TSA

+TSA

-1

1

3

5

7

-1800 -1300 -800 -300

Met

hyl-

H3-

K9

enri

chm

ent

Position from +1

EF

hMLH1

GAPDH

B B BB I III

TSA++ ++--- -Ab-++ + + ---

-TSA+TSA

-1

0

1

2

3

-1800 -1300 -800 -300

Ace

tyla

ted

H3

enri

chm

ent

A

GAPDH

hMLH1B B BB I III

TSA++ ++--- -Ab-++ + + ---

Position from +1

B-TSA+TSA

Page 3: -1787

29

Figure 3

-1

1

3

5

7

-1800 -1300 -800 -300

Position from +1

-5-Aza-dC+5-Aza-dC

E

Met

hyl-

H3-

K9

enri

chm

ent

F

hMLH1

GAPDH

5-Aza-dC

Ab

BB II

- - - -

+ -+ -

B BI I

+ +++

+ + --

-1

1

3

5

7

-1800 -1300 -800 -300

-5-Aza-dC+5-Aza-dC

Position from +1

C

Met

hyl-

H3-

K4

enri

chm

ent D

GAPDH

5-Aza-dC

Ab

BB II

- - - -

+ -+ -B BI I

+ +++

+ + --

hMLH1

-1

1

3

5

7

-1800 -1300 -800 -300

B

BB II

- - - -

+ -+ -

hMLH1

GAPDH

5-Aza-dC

Ab

B BI I

+ +++

+ + --

Position from +1

AA

cety

late

d H

3en

rich

men

t-5-Aza-dC+5-Aza-dC

Page 4: -1787

31

Fig

ure

4 Acetylated H3Enrichment

Methyl-H3-K4Enrichment

Methyl-H3-K9Enrichment

Posi

tion

from

+1

24 h

-100

0-8

00-6

00

0246 -1135 02468

-100

0-8

00-6

00

-1135 0246

-113548

h

-100

0-8

00-6

00

02468 0246

-1135

5 d

-100

0-8

00-6

00

0246

0246

-11357

12 h

drug

moc

k

Acetylated H3Enrichment

Methyl-H3-K4Enrichment

Methyl-H3-K9Enrichment

Posi

tion

from

+1

24 h

-100

0-8

00-6

00

0246 -1135 02468

-100

0-8

00-6

00

-1135 0246

-113548

h

-100

0-8

00-6

00

02468 0246

-1135

5 d

-100

0-8

00-6

00

0246

0246

-11357

12 h

drug

moc

kdr

ugm

ock

Page 5: -1787

33

+ - RT

GAPDH

hMLH1

mock5-A

za-dC

+ + + + + + +- - -- -- -

mockmock

mock5-A

za-dC

5-Aza-

dC

5-Aza-

dC

dH 2O

12 h 24 h 48 h 5 d

B

mock

UMU UUUUUU U UU UMMMMM MMMMMM

5-Aza

-dC

mock

5-Aza

-dC

5-Aza

-dC

5-Aza

-dC

mock

mock

RKOSW

480

PCR dH2O

Bisulfi

te dH

2O

12 h 24 h 48 h 5 d

A

Figure 5

Page 6: -1787

53

β-Actin

H3.3-HA

16 17 18 19 20 21 22 23 24WT

WT

1 2 3 4 5 8 9 10 11 12 14 15β-Actin

H3.3-HA

B

A

18 bplinker

408 bp 90 bp

H3.3 3xHA

Clone 10

Clone 16

WT

DAPIAnti-HA MergeC

D 1 3 4 116 12 13108 92 RKO 2

β-Actin

H3.3-HA

Figure 6

Page 7: -1787

55

Figure 7

B

1 2 3 4 6 RKO 2

5 7 8 9 10 WT

β-Actin

H3.3-HA

13 14 15 16 17 18 19 2011 12

β-Actin

H3.3-HA

A

RKO 2

1 2 3 4 6 RKO 2

WT

8 9 10 11 12

β-Actin

H3.3-HA

C

β-Actin

H3.3-HA

RKO

WT

1 3 4 11 18 SW48

0 W

TSW

480

clon

e 20

RKO Clones

Page 8: -1787

56

Figure 8

1 3 4 11 18 18 Ig

GRKO W

T

RKO Clones

SW48

0 cl

one 2

0

SW48

0 W

T

1 3 4 11 18 RKO WT

RKO Clones

Figure 8. H3.3-HA can be immunoprecipitated with anti-HA.

Whole cell (top panel) or nuclear (bottom panel) lysates were

immunoprecipitated with an anti-HA antibody. Numbers across the

top indicate clone number. Whole cell lysate from RKO clone 18 was

incubated with normal rabbit IgG as a negative control.

Page 9: -1787

58

Figure 9

B

0

2468

1012

1416

18

-1000 -800 -600

Position from +1

Met

hyl-

H3-

K4

Enr

ichm

ent

SW480 cloneSW480 WTRKO cloneRKO WT

A

0

1

2

3

4

-1000 -800 -600

H3.

3 E

nric

hmen

t

Position from +1

SW480 cloneSW480 WTRKO cloneRKO WT